Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure

Aging

Volumn 6, Issue 2, 2014, Pages 140-148

  Vays, Valeriya B ^a   Eldarov, Chupalav M ^a   Vangely, Irina M ^a   Kolosova, Nataliya G ^a,b   Bakeeva, Lora E ^a   Skulachev, Vladimir P ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Aging; Mitochondria; Mitochondria targeted antioxidant skq1; Oxidative stress; Sarcopenia; Ultrastructure

Indexed keywords

10 (6' PLASTOQUINONYL)DECYLTRIPHENYLPHOSPHONIUM; 10-(6'-PLASTOQUINONYL)DECYLTRIPHENYLPHOSPHONIUM; DRUG DERIVATIVE; PLASTOQUINONE;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; MALE; MITOCHONDRION; RANDOMIZATION; RAT; SARCOPENIA; SKELETAL MUSCLE; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; MALE; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; PLASTOQUINONE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SARCOPENIA;

EID: 84897911125     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100636     Document Type: Article

References (31)

1. Burks TN and Cohn RD. One size may not fit all: anti-aging therapies and sarcopenia. Aging (Albany NY). 2011; 3:1142-1153.
2. Skulachev VP. Cationic antioxidants as a powerful tool against mitochondrial oxidative stress. Biochem Biophys Res Commun. 2013; 441:275-279.
3. Fiskum G, Rosenthal RE, Vereczki V, Martin E, Hoffman GE, Chinopoulos C and Kowaltowski A. Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J Bioenerg Biomembr. 2004; 36:347-352.
4. Murphy AN, Fiskum G and Beal MF. Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab. 1999; 19:231-245.
5. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life. 2001; 52:159-164.
6. Dawson TM and Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science. 2003; 302:819-822.
7. Skulachev VP. Aging and programmed death phenomena, in: T. Nystrom, H.D. Osiewacz (Eds.). 2003:191-238.
8. Beal MF. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. J Bioenerg Biomembr. 2004; 36:381-386.
9. Bossy-Wetzel E, Schwarzenbacher R and Lipton SA. Molecular pathways to neurodegeneration. Nat Med. 2004; 10 Suppl:S2-9.
10. Shen J and Cookson MR. Mitochondria and dopamine: new insights into recessive parkinsonism. Neuron. 2004; 43:301-304.
11. Longo VD, Mitteldorf J and Skulachev VP. Programmed and altruistic ageing. Nat Rev Genet. 2005; 6:866-872.
12. Skulachev VP. What is "phenoptosis" and how to fight it? Biochemistry (Mosc). 2012; 77:689-706.
13. Marzetti E, Hwang JC, Lees HA, Wohlgemuth SE, Dupont-Versteegden EE, Carter CS, Bernabei R and Leeuwenburgh C. Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochim Biophys Acta. 2010; 1800:235- 244.
14. Antonenko YN, Avetisyan AV, Bakeeva LE, Chernyak BV, Chertkov VA, Domnina LV, Ivanova OY, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Muntyan MS, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Mosc). 2008; 73:1273-1287.
15. Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG, Kopnin BP, Korshunova GA, Lichinitser MR, et al. An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta. 2009; 1787:437-461.
16. Skulachev VP. Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases. J Alzheimers Dis. 2012; 28:283-289.
17. Rumyantseva YV, Fursova A, Fedoseeva LA and Kolosova NG. Changes in physicochemical parameters and alpha-crystallin expression in the lens during cataract development in OXYS rats. 5. Biochemistry (Mosc). 2008; 73:1176-1182.
18. Zhdankina AA, Fursova A, Logvinov SV and Kolosova NG. Clinical and morphological characteristics of chorioretinal degeneration in early aging OXYS rats. Bull Exp Biol Med. 2008; 146:455-458.
19. Stefanova NA, Fursova A and Kolosova NG. Behavioral effects induced by mitochondria-targeted antioxidant SkQ1 in Wistar and senescence-accelerated OXYS rats. J Alzheimers Dis. 2010; 21:479-491.
20. Markovets AM, Saprunova VB, Zhdankina AA, Fursova A, Bakeeva LE and Kolosova NG. Alterations of retinal pigment epithelium cause AMD-like retinopathy in senescenceaccelerated OXYS rats. Aging (Albany NY). 2011; 3:44-54.
21. Kozhevnikova OS, Korbolina EE, Ershov NI and Kolosova NG. Rat retinal transcriptome: effects of aging and AMD-like retinopathy. Cell Cycle. 2013; 12:1745-1761.
22. Shabalina IG, Kolosova NG, Grishanova A, Solov'ev VN, Salganik RI and Solov'eva NA. Oxidative phosphorylation activity, F0F1-ATPase and level of liver mitochondrial cytochromes in rats with congenitally increased ability for free radical formation. Biochemistry (Mosc). 1995; 60:1563-1568.
23. Neroev VV, Archipova MM, Bakeeva LE, Fursova A, Grigorian EN, Grishanova AY, Iomdina EN, Ivashchenko Zh N, Katargina LA, Khoroshilova-Maslova IP, Kilina OV, Kolosova NG, Kopenkin EP, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry (Mosc). 2008; 73:1317-1328.
24. Obukhova LA, Skulachev, V.P. and N.G. Kolosova. Mitochondria-targeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats. Aging (Albany NY). 2009; 1:389-401.
25. Amstislavskaya TG, Maslova LN, Gladkikh DV, Belousova, II, Stefanova NA and Kolosova NG. Effects of the mitochondriatargeted antioxidant SkQ1 on sexually motivated behavior in male rats. Pharmacol Biochem Behav. 2010; 96:211-216.
26. Gauthier GF and Padykula HA. Cytological studies of fiber types in skeletal muscle. A comparative study of the mammalian diaphragm. J Cell Biol. 1966; 28:333-354.
27. Bubenzer HJ. Die Dunnen und die Dicken Muskelfasern des Swerchfels der Ratte. Z Zellforsch Mikrosk Anat. 1966; 2:52-57.
28. Bubenzer HJ. Die Strukturen der Skelettmuskelfasern im Hindblock auf ihre Funktionen. Umschau. 1967; 69:551-565.
29. Bakeeva LE, Chentsov Yu S and Skulachev VP. Mitochondrial framework (reticulum mitochondriale) in rat diaphragm muscle. Biochim Biophys Acta. 1978; 501:349-369.
30. Green DE, Asai J, Harris RA and Penniston JT. Conformational basis of energy transformations in membrane systems. 3. Configurational changes in the mitochondrial inner membrane induced by changes in functional states. Arch Biochem Biophys. 1968; 125: 684-705.
31. Kolosova NG, Stefanova NA, Muraleva NA and Skulachev VP. The mitochondria-targeted antioxidant SkQ1 but not Nacetylcysteine reverses aging-related biomarkers in rats. Aging (Albany NY). 2012; 4:686-694.